MINERVA NEUROSCIENCES INC's ticker is NERV and the CUSIP is 603380106. A total of 78 filers reported holding MINERVA NEUROSCIENCES INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $363,000 | -15.4% | 60,329 | 0.0% | 0.08% | 0.0% |
Q4 2019 | $429,000 | -8.3% | 60,329 | 0.0% | 0.08% | -5.8% |
Q3 2019 | $468,000 | +37.6% | 60,329 | 0.0% | 0.09% | +22.9% |
Q2 2019 | $340,000 | -28.3% | 60,329 | 0.0% | 0.07% | -32.0% |
Q1 2019 | $474,000 | +16.5% | 60,329 | 0.0% | 0.10% | +5.1% |
Q4 2018 | $407,000 | -47.1% | 60,329 | -1.6% | 0.10% | -38.0% |
Q3 2018 | $770,000 | +86.4% | 61,329 | +22.7% | 0.16% | +75.6% |
Q2 2018 | $413,000 | +230.4% | 50,000 | +150.0% | 0.09% | +1185.7% |
Q1 2018 | $125,000 | +3.3% | 20,000 | 0.0% | 0.01% | +16.7% |
Q4 2017 | $121,000 | -20.4% | 20,000 | 0.0% | 0.01% | -25.0% |
Q3 2017 | $152,000 | -14.1% | 20,000 | 0.0% | 0.01% | -11.1% |
Q2 2017 | $177,000 | +118.5% | 20,000 | +100.0% | 0.01% | +125.0% |
Q1 2017 | $81,000 | -31.4% | 10,000 | 0.0% | 0.00% | -42.9% |
Q4 2016 | $118,000 | -16.3% | 10,000 | 0.0% | 0.01% | -12.5% |
Q3 2016 | $141,000 | +38.2% | 10,000 | 0.0% | 0.01% | +33.3% |
Q2 2016 | $102,000 | – | 10,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 449,500 | $1,429,000 | 0.58% |
Opaleye Management Inc. | 767,400 | $2,440,000 | 0.48% |
FRAZIER MANAGEMENT LLC | 550,000 | $1,749,000 | 0.16% |
FEDERATED HERMES, INC. | 9,610,200 | $30,560,000 | 0.07% |
Artal Group S.A. | 760,000 | $2,417,000 | 0.06% |
ARMISTICE CAPITAL, LLC | 500,000 | $1,590,000 | 0.06% |
NEXPOINT ASSET MANAGEMENT, L.P. | 63,114 | $201,000 | 0.04% |
Cormorant Asset Management, LP | 238,817 | $759,000 | 0.03% |
ACADIAN ASSET MANAGEMENT LLC | 1,705,195 | $5,423,000 | 0.02% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 419,104 | $1,333,000 | 0.01% |